ArticleScientific reports2017

Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin.

Shengpeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.